Pincer Biotech expands the management team through a collaboration with Marigold Innovation. Through this collaboration, Charlotte Dyring, PhD, is appointed new Chief Executive Officer, effective immediately. Dr. Dyring brings expertise in growing biotech start-ups and raising capital. She is a co-founder and former CEO of ExpreS²ion Biotechnologies, a successful spin-off from Affitech listed on Nasdaq First North, Stockholm. Marigold Innovation provides a team of industry executives whose focus is to turn life science ideas into commercial successful companies. For more information about Marigold Innovation, see www.marigold-innovation.com.